C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2)
C1-Inhibitor replacement therapy is regarded as the gold standard for acute attacks of hereditary angioedema (HAE) especially for laryngeal, facial and abdominal attacks.
Saved in:
Published in: | Journal of allergy and clinical immunology Vol. 123; no. 2; p. S99 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
St. Louis
Mosby, Inc
01-02-2009
Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | C1-Inhibitor replacement therapy is regarded as the gold standard for acute attacks of hereditary angioedema (HAE) especially for laryngeal, facial and abdominal attacks. |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2008.12.358 |